Новые технологии и оптимизация самоконтроля у детей, больных сахарным диабетом 1-го типа
Диссертация
В последние два десятилетия отмечается драматическое увеличение заболеваемости сахарным диабетом I типа у детей во всем мире. В связи с этим, со всё большей актуальностью встает вопрос об оптимизации методов лечения этого тяжелого заболевания и предотвращении отдаленных его осложнений, к коим относятся диабетическая ретинопатия, приводящая к слепоте, нефроиатия, приводящая к хронической почечной… Читать ещё >
Содержание
- 1. ОБЗОР ЛИТЕРАТУРЫ
- К истории развития инсулиновых помп
- Применение инсулин- помповой терапии в клинической практике
- Применение инсулиновых помп у детей
- Применение систем длительного монпторнроианпи гликемии в клинической практике
- Перспективы развития искусственной поджелудочной железы
- 2. МАТЕРИАЛЫ 11 МЕТОДЫ Пациенты
- Технологии, использованные в этом исследовании
- Статистическая обработка результатов
- 3. РЕЗУЛЬТАТЫ ПРОВЕДЕННЫХ ИССЛЕДОВАНИЙ Результаты использования инсулин- помповой тсрапнн у пациентов с сахарным диабетом 1 типа
- Сравнение результатов применения пнеулннов Лнзнро и Аспарт при использовании инсулиновой помпы у пациентов с сахарным диабетом 1 типа
- Сравнение результатов применения инсулина Гларгнн и ннсулнновой помпы у пациентов с сахарным диабетом 1 типа
- Результаты использования системы длительного моннторпрования гликемии у пациентов с сахарным диабетом 1 типа
Список литературы
- Анциферов М.Б., Майоров АЛО. // Реферативный сборник «Новости науки и техники». Серия Медицина. Выпуск «Клиническая эндокринология», Москва, ВИНИТИ, 1997. 7- с. 8.
- Анциферов М.Б., Майоров А. Ю., Ристич С., Дедов И. И., Сергеев A.B. //Клиническая фармакология и терапия. 1997-№ 1.-е. 68−70.
- Балаболкин М.И. Полноценная жизнь при диабете. // М., 1995, с. 112.
- Балаболкин М.И. Сахарный диабет.- М.: Медицина, 1994.- 384 с.
- Балаболкин М.И. Сахарный диабет: как сохранить полноценная жизнь. //М., 1998, с. 210.
- Дедов И.И. Сахарный диабет в Российской федерации: проблемы и пути решения. // Сахарный диабет 1998, № 1, с. 7−19.
- Дедов И.И., Балаболкин М. И., Клебанова Е. М. современные аспеты трансплантации островкой поджелудочной железы при сахарном диабете. // Сахарный диабет 2004, № 2, с. 30−34.
- Дедов И.И., Кураева T.JI., Петеркова В. А., Емельянов А. О. Современная тактика инсулинотерапни сахарного диабета у детей и подростков // Пособие для врачей -2004.
- Дедов И.И., Кураева T.JI., Петеркова В. А., Щербачева JI.H., Александрова И. И., Волеводз H.H., Ремизов О. В., Титович Е. В., Миленькая Т. М., Емельянов А. О. Осложнения сахарного диабета у детей и подростков // Пособие для врачей -2003.
- Дедов И.И., Кураева Т. Л., Петеркова В. А., Щербачева Л. Н., Александрова И. И., Волеводз H.H., Ремизов О. В., Миленькая Т. М., Светлова Г. П. Специфические хронические осложнения сахарного диабета у детей и подростков // Пособие для врачей -2004.
- Дедов И.И., Кураева T.JI., Петеркова В. А., Щербачева JI.H. Сахарный диабет у детей и подростков // Руководство для врачей -2002.
- Дедов И.И., Сунцов Ю. И., Кудрякова C.B. Экономические проблемы сахарного диабета в России. // Сахарный диабет 2000, № 3, с. 56−59.
- Дедов И.И., Шестакова М. В. Сахарный диабет // Руководство для врачей, 2003
- Жуковский М.А., Щербачева JI.H., Алексеева P.M., Трофименко JI.H. Сахарный диабет у детей. // Справочное издание по методам лечения. 1989, с 77−80.
- Искусственная поджелудочная железа. // Больщая медицинская энциклопедия. Москва, 1982, Г. 20, с 238−239.
- Касаткина Э.П. Современные тенденции в терапии инсулинзависимой формы сахарного диабета. // Пробл. Эндокринол. 1986-№, с. 42−45.
- Касаткина Э.П. Сахарный диабет у детей.- Москва: Медицина, 1994.-383 С.
- Петеркова В.А., Волсводз II.II. Инсулин ультракороткого действия «Хумалог» в лечении сахарного диабета 1 типа у детей и подростков. // Методические рекомендации (№ 13) 2001.
- Alemzadeli R, Loppnow C, Parton E, Kirby M: Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 5:167−173,2003
- Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB: Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 26:662−667, 2003
- Bak JF, Nielsen OH, Pedersen O, Beck-Nielsen II: Multiple insulin injections using a pen injector versus insulin pump treatment in young diabetic patients. Diabetes Res 6:155−158, 1987
- Beck-Nielsen H, Richelscn B, Schwartz Sorensen N, Hother Nielsen O: Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life. Diabetes Res 2:37−43, 1985
- Bell D, Ackerson C, Cutter G, Clements R: Factors associated with discontinuation of continuous insulin infusion. Am J Med Sci 295:23−28, 1988
- Bell DS, Ovalle F. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy. Endocrine Pract 6:357−360,2000
- Bell DS, Ovalle F: Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy. Endocr Pract 6:357−360,2000
- Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J: Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther 6:105−113,2004
- Bode BW, Gross TM, Thornton KR, Mastrototaro JJ: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 46:183−190, 1999
- Bode BW, Steed RD, Davidson PC: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19:324−327, 1996
- Boland EA, Grey M, Fredrikson I, Tamborlane WV. CSII: a «new» way to achieve strict metabolic control, decrease severe hypoglycemia and enhance coping, in adolescents with type 1 diabetes. Diabetes Care 1999- 22: 177 994
- Bougneres PF, Landier MD, Lemniel C, Mensire A, Chaussain JL Insulin pump therapy in young children with type 1 diabetes. J Pediatr 105:212−217, 1984
- Brambilla P, Artavia-Loria E, Chaussain JL, Bougneres PF: Risk of ketosis during intensive insulin therapy in pre-schoolage diabetic children. Diabetes Care 10:44−48, 1987
- Brmk SJ, Stewart C: Insulin pump treatment in insulin-dependent diabetes mellitus: children, adolescents, and young adults. JAMA 255:617−621, 1986
- Cameron FJ, Ambler GR: Does continuous glucose monitoring have clinical utility in contemporary management of diabetes? J Paediatr Child Health 40:79−84, 2004
- Champion MC, Shepher GA, RodgerNW, Dupre J: Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes 29:206−212,1980
- Chantelau E, Schiffers T, SchutzeJ, Hansen B: Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ Couns 30:167−175, 1997
- Chase HP, Kim LM, Owen SL, MacKenzie TA, Klingensmith GJ, Murtfeldt R, Garg SK: Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 107:222−226,2001
- Chase HP, Roberts MD, Wightman C, Klingensmith G, Garg SK, Van Wyhe M, Desai S, Harper W, Lopatin M, Bartkowiak M, Tamada J, Eastman RC: Use of the GlucoWatch Biographer in children with type 1 diabetes. Pediatrics 111:790−794,2003
- Chen R, Yogev Y, Ben-IIaroush A, Jovanovic L, Ilod M, Phillip M: Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J Matern Fetal Neonatal Med 14:256−260, 2003
- Cheyne E, Kerr D: Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev 18 (Suppl. 1):S43-S38, 2002
- Christensen CK, Christiansen JS, Christensen T, llennansen K, Mogensen CE: The effect of six months continuous subcutaneous insulin infusion on kidney function and size in insulin-dependent diabetics. Dtabet Med 3:2932,1986
- Clarke WL, Cox DJ, Gonder-Frederick LA, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 10:622−628, 1987
- Conrad SC, Mastrototaro JJ, Gitelman SE: The use of a continuous glucose monitoring system in hypoglycemic disorders. J Pediatr Endocrinol Metab 17:281−288, 2004
- Cormis RT, Taylor TR, Gordon MJ, Mecklenburg RS, Liljenquist JE, Stephens JW, BaKerMS: Changes in cognitive and social functioning ofdiabetic patients following initiation of insulin infusion therapy, Exp Aging Res 15:51−60, 1989
- Crawford LM, Sinba RN, Odell RM, Comi RJ: Efficacy of insulin pump therapy: mealtime delivery is the key factor. Endocr Pract 6:239−243,2000
- Crawford LM, Sinha RN, Odell RM, Comi RJ. Efficacy of insulin pump therapy- mealtime delivery is the key factor. Endocr Pract 6:239−243, 2000
- Dali JS, Toricscn P, Ilanssen K, Sandvik L, Aagenes O: Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes 36:1−5, 1987
- Deiss D, Hartmann R, Hoeffe J, Kordonouri O: Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatr Diabetes 5:117−121,2004
- Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes meliitus. N EnglJ Med 329:977−985, 1993
- Diabetes Control and Complications Trial: Implementation or treatment protocols in the diabetes control and complications trial. Diabetes Care 18:361−376, 1995
- Diabetes Research in Children Network (DirecNet) Study Group: The accuracy of the CGMS in children with type 1 diabetes: results of thediabetes research in children network (DirecNet) accuracy study. Diabetes Technol Ther 5:781−789,2003
- Djakoure-PIatonofF C, Radermercker R, Reach G, Slama G, Selam JI: Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabete Metab 29:159−162,2003
- Dobson L, Sheldon CD, Hattersley AT: Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 21:691−696, 2004
- Esmatjes E, Flores L, Vidal M, Rodriguez L, Cortes A, Almirall L, Ricart MJ, Gomis R: Hypoglycaemia after pancreas transplantation: usefulness of a continuous glucose monitoring system. Clin Transplant 17:534−538,2003
- Feldman B, Brazg R, Schwartz S, Weinstein R: A continuous glucose sensor based on wired enzyme technology: results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 5:769−779,2003
- Felsing W, Bibergeil H, Menzel R, Albrecht G, Felsing U, Dabels J, Reichel G, Luder C: Results of treatment with continuous subcutaneousinsulin infusion (CSII) in insulin-dependent (type 1) diabetics. Exp Clin Endocrinol 83:136−142, 1984
- Flamm CR: Use of intermittent or continuous interstitial glucose monitoring in patients with diabetes mellitus. Technology Evaluation Center. Blue Cross and Blue Shield Association Assessment Program. Vol. 18, No. 16. December 2003
- Floyd JC, Cornell RG, Jacober SJ, Griffith LE, Funnell MM, Wolf II, Wolf PM: Aprospective study identifying risk factors for discontinuance of insulin pump therapy. Diabetes Care 16:1470−1478,1993
- Foley-Nolan D, Foley-Nolan A, Temperley D, Devlin J: Diabetics treated with continuous subcutaneous insulin infusion pumps. IrMedJ82:159−160, 1989
- Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 27:734−738, 2004
- Goicolea Opacua 1, Hernandez Colau 1, Vazquez Garcia J: Comparative study between the subcutaneous continuous insulin infusion pump and optimized conventional treatment: effects at 6 months. Rev Clini Esp 179:37,1986
- Goldberg PA, Siegel MD, Russell RR, Sherxvin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE: Experience with the Continuous Glucose Monitoring System in a medical intensive care unit. Diabetes Technol Ther 6:339−347,2004
- Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM: Tests of glycemia in diabetes. Diabetes Care 18:896−909, 1995
- Golf C, DiMatteo M, Gelberg L: The role of patient participation in the doctor visit: implications for adherence to diabetes care. Diabetes Care 19:1153−1164, 1996
- Greene SA, Smith MA, BaumJD: Clinical application of insulin pumps in the management of insulin dependent diabetes. Arch Dis Child 58:578−581, 1983
- Grimm JJ, Haardt MJ, Thibult N, Goicolea I, Tchobroutsky G, Slarna G: Lifestyle, metabolic control and social implications of pump therapy in 54 routine type 1 diabetic patients. DiabeteMetab 13:3−11, 1987
- Grizzle JE: The two-period change over design and its use in clinical trials. Biometrics 21:467−480, 1965
- Grobe H, Seibold H, Ullrich K, MuflerLimmroth 5, Ziegler R: Continuous subcutaneous insulin infusion in the treatment of insulin-dependent diabetes mellitus. Monatsschr kinderheilkd 136:81−84, 1988
- Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ: Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2:49−56, 2000
- Gross TM, Mastrototaro JJ: Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol Ther 2(Suppl. 1):S19-S26, 2000
- Guerci B, Floriot M, Bohme P, Durain D, Benichou M, Jellimann S, Drouin P: Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care 26:582−589, 2003
- Guerd B, Meyer L, Delbachian 1, Kolopp M, Ziegler O, Drouin P: Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 40:175−180, 1998
- Guinn TS, Bailey GJ, Mecklenburg RS: Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care 11:4651,1988
- Hang PJ, Kelly TM, Cannon RB, Edwards CQ: A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic rieuropathy. J Neurol Sci 82:123−132, 1987
- Hanson C: Developing systemic models of the adaptation of youths with diabetes. In Stress and Coping in Child Health. LaGreca A, Siegel L, Wallander J, Walker E, Eds. New York, Guilford, p. 212−241, 1992
- Hay LC, Wilmshurst EG, Fulcher G: Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 5:19−26, 2003
- Helve E, Koivisto VA, LehtonenA, Pelkonen R, HuttunenJ, Nikkila E: A crossover comparison of continuous insulin infusion and conventional injection treatment of type 1 diabetes. Acta Med Scand 221: 385−393, 1987
- Ilershkovitz E, Rachmel A, Ben-Zaken II, Phillip M: Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 24:863−869, 2001
- Jeha GS, Karaviti LP, Anderson B, Smith EO, Donaldson S, McGirk TS, Haymond MW: Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes. Diabetes Care 27:2881−2886, 2004
- Johnson 5: Health behavior and health status: concepts, methods and applications. J Ped Psychol 19:129−141, 1994
- K. Rebrin, G. M. Steil, A.E. Panteleon, F. Hariri, C. Darwin, M.F. Saad. Closed loop subcutaneous insulin delivery based on subcutaneous glucose sensing in adults. //Abstract volume of the 40-h annual meeting 2004 ofEASD. OP 43.242.
- Kaufman FR, Austin J, Neinstein A, Jeng L, Halvorson M, Devoe DJ, Pitukcheewanont P: Nocturnal hypoglycemia detected with the continuous glucose monitoring system in pediatric patients with type 1 diabetes. J Pediatr 141:625−630, 2002
- Kaufman FR, Halvorson M, Kim C, Pitukcheewanont P: Use of insulin pump therapy at nighttime only for children 7−10 years of age with type 1 diabetes. Diabetes Care 23:579−582,2000
- Kelly TM, Sanborn GE, IlaugPJ, Edwards CQ: Effect of insulin infusion pump use on diabetic retinopathy. Arch Ophthalmol 102:11 561 159, 1984
- Kerssen A, de Valk IIW, Visser GII: The Continuous Glucose Monitoring System during pregnancy of women with type 1 diabetes mellitus: accuracy assessment. Diabetes Technol Tlier 6:645−651,2004
- Kitabcbi AE, Fisher JN, Burghen GA, Gaylord MS, Blank NM: Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes. Diabetes Care 2:421−424, 1979
- Klonoff DC: The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges. Diabetes Care 27:834−836, 2004
- Knight G, Boulton A, Drury J, Ward J: Long term glycaemic control by alternative regimens in a feasibility study of continuous subcutaneous insulin infusion. Diabetes Res 3:355−358, 1986
- Knight G, Boulton A, Ward JD: Experience or continuous subcutaneous insulin infusion in the outpatient management of diabetic teenagers. Diabet Med 3:82−84, 1986
- Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-IIyman D, Schlundt D, Clarke W: Assessment of risk for severe hypoglycemia amongadults with 1DDM: validation of the low blood glucose index. Diabetes Care 21:1870−1875,1998
- Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL: Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 27:1922−1928, 2004
- Kronert K, HulserJ, Luft D, StetterT, Egg-stein M: Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral autonomic nerve dysfunction. J Clin Endocrinol Metab 64:1219−1223, 1987
- Kubiak T, Hermanns N, Schreckling HJ, Kulzer B, Haak T: Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med 2:487−490, 2004
- Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ: Physiological differences between interstitial glucose and blood glu-cose measured in human subjects. Diabetes Care 26:2405−2409, 2003
- Larsen J, Ford T, Lyden E, Colling C, Mack-Shipman L, Lane J: What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system? Endocr Pract 10:324−329,2004
- Lauritzen T, Larsen IIW, Frost-Larsen K, Deckert T: Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1:200−204, 1983
- Lauritzen T, Pramming S, Deckert T, Binder C. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 1983- 24:326−9
- LecavalicrL, HavrankovaJ, HametP, Cliiasson J: Effects of continuous subcutaneous insulin infusion versus multiple injections on insulin receptors in insulin-dependent diabetics. Diabetes Care 10: 300−305, 1987
- Leichter SB, Schreiner ME, Reynolds R, Bolick T: Long-term follow-up of diabetic patients using insulin infusion pumps: considerations for future clinical application. Arch Intern Med 145:1409−1412, 1985
- Levy-Marchal C, Czernichow P: Feasibility of continuous subcutaneous insulin infusion in young diabetic patients. Diabete Metab 14:108−113,1988
- Lombardo A, Scavino 5, Scornavacca G, Oliva G, Sipione C, Cacciola R, Motta L: Continuous subcutaneous insulin infusion: a long-term study. Acta Diabetol Lat 23:1−12, 1986
- Ludvigsson J, Hanas R: Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 111:933−938,2003
- Lustman P, Anderson R, Freedland K, DeGroot M, Carney R, Clouse R: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934−942, 2000
- Maniatis Ak, Klingensmlth GJ, Slover RH, Mowry CJ, Chase HP: Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 107:351- 356, 2001
- Manuel-y-Keenoy B, Vertommen J, Abrams P, Van Gaal L, De Leeuw I, Messen D, Poscia A: Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device. Diabetes Metab Res Rev 20 (Suppl. 2):S24-S31, 2004
- Maran A, Crepaldi C, Avogaro A, Catuogno S, Burlina A, Poscia A, Tiengo A: Continuous glucose monitoring in conditions other than diabetes. Diabete Metab Res Rev 20 (Suppl. 2):S50-S55,2004
- Marshall SM, Home PD, Taylor R, Alberti K: Continuous subcutaneous insulin infusion versus injection therapy: a randomized crossover trial under usual diabetic clinic conditions, Diabet Med 4:521- 525, 1987
- McGovvan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 25:1499−1503,2002
- Mecklenburg RS, Benson EA, BensonJW, Fredlund P, Guinn T, Metz R, Nielsen R, Sanner C: Acute complications associated with insulin infusion pump therapy: report of experience with 161 patients. JAMA 252:3265−3269, 1984
- Mecklenburg RS, Benson JW, Becker NM, Brazel PL, Fredlund PN, Metz RJ, Nielsen n, Sannar C, Steenrod W: Clinical sue of the insulin infusion pump in 100 patients with type 1 diabetes. N Engl J Med 307: 513 518, 1982
- Mecklenlurg RS, Benson EA, BensonJW, Blumenstein BA, Fredlund P, Guinn TS, MetzRJ, Nielsen RL: Long-term metabolic control with insulinpump therapy: report of experience with 127 patients. N Eng, l J Med 313:465−468, 1985
- Metzger M, Leibovvitz G, Wainstein J, Glaser B, Raz I: Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 25:1185−1191,2002
- Miedema K: Laboratory tests in diagnosis and management of diabetes mellitus: practical considerations. Clin Chem Lab Med 41:12 591 265, 2003
- Nathan DM, Lou P, Avruch J: Intensive conventional and insulin pump therapies in adult type 1 diabetes: a crossover study. Ann Intern Med 97:31−36, 1982
- Nyback-Nakell A, von Ileijne M, Adamson U, Lins PE, Landstedt-Hallin L: Accuracy of continuous nocturnal glucose screening after 48 and 72 hours in type 2 diabetes patients on combined oral and insulin gherapy. Diabetes Metab 30:517−521,2004
- Olsen T, Ridhelsen B, Ehlers N, Beck-Nielsen H: Diabetic retinopathy after 3 years' treatment with continuous subcutaneous insulin infusion (CSII). Acta Ophtalmol 85:185−189, 1987
- Pfuetzner A, Caduff A, Larbig M, Schrepfer T, Forst T: Impact of posture and fixation technique on impedance spectroscopy used for continuous and non-invasive glucose monitoring. Diabetes Technol Tlier 6:435−441,2004
- Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. BMJ 1978- 1:204−7.
- Pickup JC, Keen H, Viberti G, Bilous it Patient reactions to long-term outpatient treatment with continuous subcutaneous insulin infusion. BMJ 282:766−768, 1981
- Pickup JC, White MC, Keen H, Parsons JA, Alberti KG: Long-term continuous subcutaneous insulin infusion in diabetics at home. Lancet 2:870−873,1979
- Pitzer KR, Desai S, Dunn T, Edelman S, Jayalakshmi Y, Kennedy J, Tamada JA, Potts RO: Detection of hypoglycemia with the GlucoWatch Biographer. Diabetes Care 24:881−885,2001
- Poscia A, Mascini M, Moscone D, Luzzana M, Caramenti G, Cremonesi P, Valgimigli F, Bongiovanni C, Varalli M: A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1). Biosens Bioelectron 18:891−898,2003
- Potts RO, Tamada JA, Tierney MJ: Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 18 (Suppl. 1):S49-S53,2002
- Reach G: Which threshold to detect hypoglycemia? Value of receiver-operator curve analysis to find a compromise between sensitivity and specificity. Diabetes Care 24:803−804,2001
- Reeves ML, Seigler DE, Ryan EA, SkylerJ: Glycemic control in insulin-dependent diabetes mellitus: comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med 72:673−680, 1982
- Reichard P, Nilson BY, RosenquistU: The effect of long term intensified insulin treatment on the development of micro-vascular complications of diabetes mellitus. N Eng 1 JMed 329:304−309,1993
- Ronn B, Mathiesen ER, yang L, Lnrup B, Deckert T: Evaluation of insulin pump treatment under routine conditions. Diabetes Res Clin Pract 3:191−196,1987
- Rubin R: Psychosocial Assessment in Core Curriculum for Diabetes Education. 3rd ed. Funnell M., Hunt C, Kulkarni K, Rubin R, Yarborough P, Eds. Chicago, American Association of Diabetes Educators, 1998
- Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 53:955−962, 2004
- Sabbah H, Mcculloch K, Fredrickson LP, Gross TM, Bode BW: Detailed data from a Continuous Glucose Monitoring System (CGMS) facilitates comprehensive diabetes management recommendations (Abstract). Diabetes 49 (Suppl. 1):A 393,2000
- Sachedina N, Pickup JC: Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med 20:1012−1015,2003
- Saurbrey N, Arnold-Larsen 5, MollerJensen B, Kuhi C: Comparison of continuous subcutaneous insulin infusion with multiple insulin injections using the NovoPen. Diabet Med 5:150−153, 1988
- Scbiffrin AD, Desrosiers M, Alevassine H, Belmonte MM: Intensified insulin therapy in the type 1 diabetic adolescents: a controlled trial. Diabetes Care 7:107−113, 1984
- Schaepelynck-Belicar P, Vague P, Simonin G, Lassmann-Vague V: Improved metabolic control in diabetes adolescents using the continuous glucose monitoring system (CGMS). Diabete Metab 29:608−612,2003
- Schiafifini R, Ciampalini P, Fierabracci A, Spera S, Borrelli P, Bottazzo GF, Crino A: The Continuous Glucose Monitoring SystemCGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev 18:324−329,2002
- Schiffnn AD, Belmonte MM: Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin: a one-year prospective study. Diabetes 331:255−264, 1982
- Schiffrtn A, Desrosiers M, Mofflatt M, Belmonte M: Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. J Pediatr 103:522−527, 1983
- Schinitz A, Christiansen JS, Christensen CK, Herman, sen K, Mogensen C: Effect of pump versus pen treatment on glycemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM). Dan Med Bull 36: 176−178, 1989
- Seigler DE, LaGreca A, Satin-Rappaport W, Reeves M, Skyler J: Psychological effects of intensification of diabetic control. Diabetes Care 5 (Suppl. l):19−23, 1982
- Shapiro J, Wigg D, Charles M, Perley M: Personality and family profiles of chronic insulin-dependent diabetic patients using portable insulin infusion pump therapy: apreliminary investigation. Diabetes Care 7:137 142, 1984
- Sharp P, Rainbow S: Continuous glucose monitoring and haemoglobin A (lc). Ann Clin Biochem 39:516−517, 2002in
- Sherwin RS, Tamborlane W, Genel M, Felig P: Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump. Diabetes Care 3:301- 308, 1980
- Skyler JS, Seigler DE, Reeves M: A coMpanson or insulin regimens in insulin-dependent diabetes mellitus. Diabetes Care 5 (Suppl. 1):11−18, 1982
- Steindel BS, Roe TR, CostinG, CarlsonM, Kaufman FR: Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 27:199−204, 1995
- Strickland AL, Strickland J: An outpatient technique for continuous subcutaneous insulin infusion in adolescents and young adults with IDDM. J S C Med Assoc 96: 386−389, 2000
- Tamada JA, Davis TL, Leptien AD, Lee J, Wang B, Lopatin M, Wei C, Wilson D, Comyns K, Eastman RC: The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2 Biographer. Diabetes Technol Ther 6:357−367,2004
- Tamborlane WV, Sherwin RS, Genel M, Fehc P: Reduction to normal of plasma glucose injuvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 300: 573−578, 1979
- Tamborlane WV, Sherwin RS, Genel M, Felic P: Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system. AmJMed 68:190−196, 1980
- Tamborlane WV, Shverin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetics by subcutaneous administration of insulin with portable infusion pump. N Engl O Med 1979- 300:573−8.
- Tanenberg RJ, Pfeifer MA: Continuous glucose monitoring system: a new approach to the diagnosis of diabetic gastroparesis. Diabetes Technol Tlier 2 (Suppl. 1):S73-S80, 2000
- The Diabetes Research in Children Network (DirecNet) Study Group: A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 28:1101−1106,2005
- Tressanchez Trias JM, Mesa Manteca J, Saninarti Sala AM, Obiols Alfonso G, Pujol Borrel R: Insulin-dependent diabetes mellitus: subcutaneous insulin therapy with a portable infusion pump. Med Clin (Barc) 80:394−397,1983
- Tsui E, BarnieA, Ross 5, ParkesR, Zinnian B: Intensive insulin therapy with insulin Lispro. Diabetes Care 24:1722−1727, 2001
- Tubiana-Rufi N, de Lonlay P, Bloch J, Czernidhovv P: Remission of severe hypoglycemic incidents in youth. Arch Pediatr 3:969−976, 1996
- UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonyl ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 352:837−853, 1998
- Varalli M, Marelli G, Maran A, Bistoni S, Luzzana M, Cremonesi P, Caramenti G, Valgimigli F, Poscia A: A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 2). Biosens Bioelectron 18:899−905,2003
- Weinzimer SA, DeLucia MC, Boland EA, Steffen A, Tamborlane WV: Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms. Diabetes Technol Ther 5:375 380,2003
- Weinzimer SA, Tamborlane WV, Chase HP, Garg SK: Continuous glucose monitoring in type 1 diabetes. Curr Diab Rep 4:95−100, 2004
- Wieliczko MC, De Menibus CH, Mallet E: Insulin therapy using a portable pump in children: apropos of a pediatric experience. Ann Pediatr (Paris) 39:535−541, 1992
- WredlingR, Lins PL, AdamsonU: Factors influencing the clinical Gluconic oi continuous suocuianeous iiisuiiii? iiiusioii in routine practice. Diabetes Res Clin Pract 19:59−67, 1993,
- Yogev Y, Ben-Haroush A, Chen R, Kaplan B, Phillip M, Hod M: Continuous glucose monitoring for treatment adjustment in diabetic pregnancies: a pilot study. Diabet Med 20:558−562,2003
- Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O: Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol 104:88−93, 2004
- Yogev Y, Ben-Hroush A, Chen R, Rosenn B, Hod M, Langer O: Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol 191:949−953,2004
- Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovic L, Hod M: Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol 101:633−638,2003
- Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121−130, 1986
- Zinman B, Tildersley II, Chiasson TJ, Tsue F, Strack T. Insulin Lispro in CSII: results of double -blind crossover study. Diabetes. 1997- 46: 440−3